Enhanced FDA Oversight Added To GAO’s “High Risk” List
This article was originally published in The Tan Sheet
Executive Summary
The Government Accountability Office has added enhanced oversight of devices, drugs and other medical products to its list of "high risk" priorities
You may also be interested in...
Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA
FDA's top leadership team will not split duties along food and medical products, sources close to the selection process say
FDA Commissioner Announcement Complicated By Daschle, Peanut Butter
The withdrawal of Tom Daschle's nomination as Health and Human Services secretary may pose a hurdle to the Obama administration's impetus to name an FDA commissioner, but does not change the two names on the shortlist
Funding Advice From FDA Science Board: Double Total Over Next Five Budgets
FDA Science Board members recommend a nearly $1.9 billion direct appropriation for the agency in fiscal 2009, a $375 million increase over 2008, and larger increases in each of the following four federal budgets